Scholars Central

LetterPublished 30 Apr 2023

Photophobia and Migraine Outcome during Treatment with Galcanezumab

Authors: Catherine Lapp

Journal of Neurology & Neurophysiology

Volume 14 · Issue 4 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The Calcitonin Gene-Related Peptide (CGRP), which affects both migraine pain and accompanying symptoms including photophobia, is crucial to the physiology of migraines. The current study sought to determine if monoclonal antibodies that target CGRP are effective in lowering ictal photophobia as well as headache and migraine frequency and disability.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology & Neurophysiology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Catherine Lapp”